Defining Waldenstrom's macroglobulinemia

被引：16

作者：

Treon, SP

Dimopoulos, M

Kyle, RA

机构：

[1] Harvard Univ, Dana Farber Canc Inst, Waldenstroms Macroglobulinemia Program, Dept Med Oncol, Boston, MA 02115 USA

[2] Harvard Univ, Dept Med, Boston, MA 02115 USA

[3] Univ Athens, Athens, Greece

[4] Mayo Clin, Rochester, MN USA

来源：

SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 02期

关键词：

D O I：

10.1053/sonc.2003.50081

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：107 / 109

页数：3

共 12 条

[1] 14q32 translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinernia [J].

Avet-Loiseau, H ;

Garand, R ;

Lodé, L ;

Robillard, N ;

Bataille, R .

SEMINARS IN ONCOLOGY, 2003, 30 (02) :153-155

[2] Treatment recommendations in Waldenstrom's macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waidenstrom's macroglobulinemia [J].

Gertz, MA ;

Anagnostopoulos, A ;

Anderson, K ;

Branagan, AR ;

Coleman, M ;

Frankel, SR ;

Giralt, S ;

Levine, T ;

Munshi, N ;

Pestronk, A ;

Rajkumar, V ;

Treon, SP .

SEMINARS IN ONCOLOGY, 2003, 30 (02) :121-126

[3]

Groves FD, 1998, CANCER-AM CANCER SOC, V82, P1078

[4] World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997 [J].

Harris, NL ;

Jaffe, ES ;

Diebold, J ;

Flandrin, G ;

Muller-Hermelink, HK ;

Vardiman, J ;

Lister, TA ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3835-3849

[5]

HARRIS NL, 1994, BLOOD, V84, P1361

[6] The malignant clone in Waldenstrom's macroglobulinemia [J].

Kriangkum, K ;

Taylor, BJ ;

Mant, MJ ;

Treon, SP ;

Belch, AR ;

Pilarski, LM .

SEMINARS IN ONCOLOGY, 2003, 30 (02) :132-135

[7] Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia:: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia [J].

Kyle, RA ;

Treon, SP ;

Alexanian, R ;

Barlogie, B ;

Björkholm, M ;

Dhodapkar, M ;

Lister, TA ;

Merlini, G ;

Morel, P ;

Stone, M ;

Branagan, AR ;

Leblond, W .

SEMINARS IN ONCOLOGY, 2003, 30 (02) :116-120

[8] Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia [J].

Owen, RG ;

Treon, SP ;

Al-Katib, A ;

Fonseca, R ;

Greipp, PR ;

McMaster, ML ;

Morra, E ;

Pangalis, GA ;

Miguel, JFS ;

Branagan, AR ;

Dimopoulos, MA .

SEMINARS IN ONCOLOGY, 2003, 30 (02) :110-115

[9] Origins of the malignant clone in typical Waldenstrom's macroglobulinernia [J].

Sahota, SS ;

Forconi, F ;

Ottensmeier, CH ;

Stevenson, FK .

SEMINARS IN ONCOLOGY, 2003, 30 (02) :136-141

[10] Genetics and cytogenetics of Waidenstrom's macroglobulinemia [J].

Schop, RFJ ;

Fonseca, R .

SEMINARS IN ONCOLOGY, 2003, 30 (02) :142-145

← 1 2 →